Avigdor Willenz has done it again

Avigdor Willenz Photo: Tamar Matsafi
Avigdor Willenz Photo: Tamar Matsafi

The Israeli entrepreneur has previously sold companies to Marvell, Amazon and Cisco. But why has Intel paid $2 billion for Habana Labs?

The sale of Habana Labs to Intel for $2 billion just three years after it was founded is an impressive feat. The deal represents yet another exit for serial entrepreneur Avigdor Willenz and yet another Israeli acquisition by Intel.

Habana's field of endeavor is the development of artificial intelligence (AI) chips. The ability to develop AI technology - to analyze data, to identify recurring patterns and to train algorithms - preoccupies just about every tech company today that wants to be innovative. Even those not already developing AI, are planning to develop it.

However, in order to undertake the very complex calculations that will let autonomous cars drive themselves or will identify diseases, it is not sufficient simply to have sophisticated algorithms. Also required is the hardware infrastructure that will enable these capabilities to become fully realized. Intel's decision to acquire Habana Labs for $2 billion is designed to provide such an infrastructure.

The most prominent personality behind Habana Labs is Willenz, a veteran entrepreneur. He was the founder and CEO of communications chip company Galileo Technology which was sold to Marvell for $2.7 billion in 2000. He also founded semiconductor platform Annapurna Labs, which was sold to Amazon for $370 million in 2015 and Leaba Semicnductor, which was sold to Cisco in 2016.

Habana Labs is not the only company developing AI chips and in particular the Israeli scene has in recent years been buzzing with such startups, so what about Habana justifies a $2 billion price tag?

Habana's chips kill two birds with one stone for Intel

Habana has developed chips for two main types of AI tasks - the training stage and the application stage. In other words, the stage in which the algorithm "learns" is a very demanding stage in terms of computer resources, and the application stage in which the system uses the insights learned in the training stage. This while some of the other companies developing AI chips do so only for one of the stages, or develop chips designed for end devices, and not for data centers.

This means that Habana's chips are not only precisely suited for Intel's needs but also kill two birds with one stone. The fact that the products are already commercially available, or in advanced stages with customers, is also a big help. Habana's chips are also ideally suited for the market that most interests Intel - the data centers market. Intel sees this as both an entrance to that market and a major future revenue source. Thus Habana's Gaudi and Goya chips are precisely what Intel needs.

While Intel is developing its own chips in this field, with the development also being carried out in Israel, Habana's chips are substantially different.

While Intel's AI chips are based on the architecture of regular CPU processors, Habana's chips are based on completely new architecture, especially designed for AI processor tasks. The fact that Intel will soon have AI chips will also give it a competitive advantage against Nvidia, which originally developed graphic processors and only then discovered that they were also suitable for the field of AI.

Intel does not plan missing the AI revolution

The acquisition is part of the global competition in the world of computer chips in which Intel's fiercest rival is Nvidia. The competition between the two companies could not be more open and they tend to snipe at each other in public forums. This will by no means be the last AI acquisition and a high stake race is likely to develop.

There is also competition from outside the field of traditional chips from Google and Amazon, which offer cloud services and are developing their own chips for data centers to try and gain a competitive advantage over each other. Intel, which in the past missed the mobile phone revolution, would be prepared to pay vast amounts of capital not to miss the AI revolution. Consequently, Intel paid a high premium for Israeli auto-tech company Mobileye, which it bought for $15.3 billion three years ago, and is now prepared to pay $2 billion for a three year old company, which has raised just $120 million.

In contrast to the acquisition of Mobileye, the current acquisition is part of Intel's core activities. Mobileye has taken Intel into a new area of endeavor but if it misses out on AI, then the next decade could be wretched for Intel. Moreover, Intel does not have a good track record with acquisitions and its performance over the years has been marred by the failure to integrate some of the companies it has bought. With Mobileye, Intel seems to be taking a different approach and letting it operate independently.

Will Intel repeat this model with Habana? It is by no means certain. Last year Intel appointed Bob Swan as CEO - he was previously CFO and he has tried to open up the company to external innovative processes and change its archaic DNA. The Habana deal is an opportunity to prove that he has successfully implemented change and prove that he can integrate acquired companies. Two of Willenz's previous exits - Annapurna to Amazon and Leaba to Cisco - were successfully integrated into those companies. Intel would be happy for that to happen with Habana.

Published by Globes, Israel business news - en.globes.co.il - on December 16, 2019

© Copyright of Globes Publisher Itonut (1983) Ltd. 2019

Avigdor Willenz Photo: Tamar Matsafi
Avigdor Willenz Photo: Tamar Matsafi
Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Peter Kash credit: personal photograph Peter Kash confident about cancer cure breakthrough

In Israel for IATI's MIXiii International Life Science and Health-Tech week, the US investor talks about his life science portfolio and the opportunities Israel must seize.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018